scispace - formally typeset
P

Paul T. Wilson

Researcher at University of California, San Francisco

Publications -  6
Citations -  1007

Paul T. Wilson is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Palmitoylation & Heterotrimeric G protein. The author has an hindex of 5, co-authored 6 publications receiving 982 citations.

Papers
More filters
Journal ArticleDOI

Lipid modifications of trimeric G proteins.

TL;DR: This work has shown how different lipid modifications of different G protein subunits affect specific protein-protein interactions and localization to specific cellular sites and regulation of these modifications, particularly palmitoylation, can provide new ways to regulate signals transmitted by G proteins.
Journal ArticleDOI

Palmitoylation is required for signaling functions and membrane attachment of Gq alpha and Gs alpha.

TL;DR: Myristoylation restores the abilities of both nonpalmitoylated alpha q and alpha s to attach to membranes and, in the case of alpha q, restores its ability to stimulate phospholipase C, whether triggered by the R183C mutation or by receptor activation.
Journal ArticleDOI

Plasma Membrane Localization of Gαz Requires Two Signals

TL;DR: Study of the effects of mutations that prevent myristoylation and/or palmitoylation of an epitope-labeled alpha subunit, alpha z, suggests that myristate and beta gamma promote stable association with membranes not only by providing hydrophobicity, but also by stabilizing attachment of palmitate.
Journal ArticleDOI

Fatty acylation of alpha z. Effects of palmitoylation and myristoylation on alpha z signaling.

TL;DR: The role played by fatty acylation of G protein alpha chains in membrane targeting and signal transmission was investigated in this article, where the authors inserted monoclonal antibody epitopes, hemagglutinin (HA) or Glu-Glu (EE), at two internal sites in three alpha subunits.
Journal ArticleDOI

The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin.

TL;DR: In this article, the effect of mutations on the function of the V2 vasopressin receptor was investigated by in vitro mutagenesis, and it was found that the inability of this mutant to stimulate adenylyl cyclase is caused by the reduced capacity for vasopressor binding and that the R181C mutation is responsible for NDI in this family.